New HIV drug MK-4646 tested with standard meds in healthy volunteers
NCT ID NCT07532304
First seen Apr 26, 2026 · Last updated May 16, 2026 · Updated 2 times
Summary
This study tests a new experimental HIV medicine, MK-4646, in 16 healthy adults to see how it interacts with two standard HIV treatments: BIC/FTC/TAF and dolutegravir. Researchers will measure drug levels in the blood and check for side effects. The goal is to ensure safety before testing in people living with HIV.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Pinnacle Research Group
RECRUITINGAnniston, Alabama, 36207, United States
Contact
Conditions
Explore the condition pages connected to this study.